N-(5-chloro-2-{(E)-3-[3-(4-fluorobenzyl)-3,8-diazabicyclo[3.2.1]oct-8-yl]-3-oxopropenyl}-4-methyl-phenyl)-2-methoxy-acetamide | 868406-99-9

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮
• 英文名称: N-(5-chloro-2-{(E)-3-[3-(4-fluorobenzyl)-3,8-diazabicyclo[3.2.1]oct-8-yl]-3-oxopropenyl}-4-methyl-phenyl)-2-methoxy-acetamide
• 英文别名: N-[5-chloro-2-[(E)-3-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-3-oxoprop-1-enyl]-4-methylphenyl]-2-methoxyacetamide
• CAS: 868406-99-9
• 化学式: C₂₆H₂₉ClFN₃O₃
• 分子量: 485.986
• InChiKey: NUDMSUNJGUKNDN-BJMVGYQFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  34
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  61.9
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• Compounds As Ccri Antagonists
  申请人：Heng Richard

  公开号：US20070196270A1

  公开（公告）日：2007-08-23

  A compound of formula I, or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases.

  化合物I的公式，或其药学上可接受的盐或酯，其中符号的含义如定义的那样，它们是CCR-1的拮抗剂，并且在药学上用于治疗与CCR-1有关的疾病和症状，例如炎症性疾病。
• BRIDGED PIPERAZINE AND PIPERIDINE DERIVATIVES AS CCR1 ANTAGONISTS
  申请人：Novartis AG

  公开号：EP1794164A2

  公开（公告）日：2007-06-13
• [EN] COMPOUNDS AS CCRI ANTAGONISTS<br/>[FR] COMPOSES ANTAGONISTES VIS-A-VIS DU RECEPTEUR DE CHIMIOKINE 1 (CCR-1)
  申请人：NOVARTIS AG

  公开号：WO2005103054A2

  公开（公告）日：2005-11-03

  A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases.